Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CE-224535 in osteoarthritic knee pain
NCT00418782Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Jan 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of CE-224535 in knee osteoarthritis (OA), sponsored by Pfizer. Started Jan 2007; status: terminated.
02
Drugs
CE-224535
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00418782.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00418782.